Skip to main content
Clinical Trials/NCT05447897
NCT05447897
Completed
Not Applicable

A Systematic Approach to Designing an Implementation Strategy to Increase Lung Cancer Screening and Smoking Cessation Treatment Among Federally Qualified Community Health Center Patients Who Smoke

University of Colorado, Denver1 site in 1 country9 target enrollmentDecember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking Cessation
Sponsor
University of Colorado, Denver
Enrollment
9
Locations
1
Primary Endpoint
Feasibility of Intervention Measure
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.

Detailed Description

Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.

Registry
clinicaltrials.gov
Start Date
December 1, 2022
End Date
May 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • FQHC implementation team including staff in the intervention FQHCs and their lung screening partners

Exclusion Criteria

  • FQHC staff or partners who leave the organization before end of study

Outcomes

Primary Outcomes

Feasibility of Intervention Measure

Time Frame: End of study, up to 16 weeks

Feasibility of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Secondary Outcomes

  • Acceptability of Intervention Measure(End of study, up to 16 weeks)
  • Intervention Appropriateness Measure(End of study, up to 16 weeks)

Study Sites (1)

Loading locations...

Similar Trials